Randomized Phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin Ototoxicity.

Journal:

Journal of Clinical Oncology

Published:

2025-05-23

DOI:

10.1200/jco.24.00905

Affiliations:

9

Authors:

17

Go to article

Institutions	Authors	Share
Decibel Therapeutics, United States of America (USA)	5.000000	0.29
Princess Alexandra Hospital, Australia	3.000000	0.18
The University of Queensland (UQ), Australia	2.000000	0.12
Peter MacCallum Cancer Centre (Peter Mac), Australia	1.500000	0.09
The University of Melbourne (UniMelb), Australia	1.500000	0.09
Fiona Stanley Hospital (FSH), Australia	1.000000	0.06
St Vincent's Hospital Melbourne, Australia	1.000000	0.06
Northwell Health, United States of America (USA)	1.000000	0.06
Lapuerta Consulting, LLC, New Zealand	1.000000	0.06

Interested in Clinical Sciences?